3189companies in the directory 652ISIN verified against the check digit 7exchanges 14sectors No real-time quotes — a reference work, not a trading platform3189companies in the directory 652ISIN verified against the check digit 7exchanges 14sectors No real-time quotes — a reference work, not a trading platform
DE · EN Newsletter
Biotech & Pharma Symbolbild · KI-generiert
Biotech & Pharma MBIO

MindBio Therapeutics Corp.

MBIO CSE Biotech & Pharma

Stock factsheet

TickerMBIO
ExchangeCSE
ISIN
WKN
SectorBiotech & Pharma
Size class Nano Cap
Market capitalisation 1 Mio. USD As of 2026-08-04

Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.

Company profile

MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) is a biotechnology company, that for several years has been conducting drug and alcohol research and has created health prediction technologies using AI and machine learning. The Company has expertise in using speech analytics as a prediction tool for drug and alcohol intoxication and has created a world first voice and AI powered prediction model for drug and alcohol intoxication for use in consumer and enterprise situations. The Company is developing a comprehensive enterprise platform using voice and powered by AI for use in detecting drug and alcohol intoxication in workplaces, law enforcement, mental health and telehealth.

Company description as published by the issuer via Canadian Securities Exchange.

Comparable companies

Companies in the Biotech & Pharma sector of a similar size.

CompanyTickerExchangeMarket cap
MindBio Therapeutics Corp.MBIO CSE1 Mio. USD
Grey Matters Health Inc. GREYCSE 1 Mio. USD
CardioComm Solutions Inc. EKGTSXV 1 Mio. USD
Appili Therapeutics Inc. APLITSX 1 Mio. USD
Kovo+ Holdings Inc. KOVOTSXV 1 Mio. USD
Nirvana Life Sciences Inc. NIRV.XCSE 1 Mio. USD
ASEP Medical Holdings Inc. ASEPCSE 1 Mio. USD

Investor Relations

Annual reports Not recorded yet
Investor presentation Not recorded yet
Analyst coverage Not recorded yet

We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.

Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.